Back

Implementation and clinical outcomes of pharmacogenetic CYP2C19 testing for clopidogrel therapy in real-world clinical practice.

15 April 2021 (08:00 - 19:20)
Organised by:
Congress Presentation Part of: ePosters Pharmacotherapy EAPC Premium Access ESC Preventive Cardiology 2021

About the speaker

Photo
Doctor Padraig Drisceoil

University Hospital Limerick, Limerick (Ireland)

334 More presentations in this session

Presentation thumbnail
A diet-related microsimulation modelling approach in the context of cardiovascular disease prevention: the ATTICA and GREECS epidemiological studies.
Professor D. Panagiotakos (Athens, GR)
Abstract Slides
Presentation thumbnail
s-VCAM-1 is an independent predictor of all-cause mortality in patients with dilated cardiomyopathy and hypokinetic non-dilated cardiomyopathy
Doctor K. Lehnert (Greifswald, DE)
Abstract Slides
Presentation thumbnail
Age-standardized prevalence of social determinants of health and associated race-ethnic disparities in stroke survivors
Doctor T. Parekh (Newark, US)
Abstract Slides
Presentation thumbnail
Impact of Proteinuria and Low eGFR on Lifetime Risk of Cardiovascular Disease Death: A Pooled Analysis of Data From the Evidence for Cardiovascular Prevention From Observational Cohorts in Japan Study
Ms Y. Imai (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Risk of cerebrovascular accidents according to weather and pollution features
Associate Professor G. Biondi-Zoccai (Latina, IT)
Abstract Slides

Access the full session

Session thumbnail
ePosters

The Event

Event poster

ESC Preventive Cardiology 2021

15 April 2021 08:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources